Cancer Tumor Markers - ELISA Blood Test Kits
Tissue architecture in tumor initiation and progression: Trends in Cancer
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries | Anticancer Research
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Frontiers | Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions - Cheng - 2021 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Frontiers | The Origins and Generation of Cancer-Associated Mesenchymal Stromal Cells: An Innovative Therapeutic Target for Solid Tumors
Clinical risk factors of gastric cancer (GC) and tumor markers in high... | Download Scientific Diagram
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text
Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine
Tumor markers in cancer diagnosis and prognosis
Serum Cytokeratin Fragment 21.1 (CYFRA 21.1) as Tumour Marker for Breast Cancer: Comparison with Carbohydrate Antigen 15.3 (CA 15.3) and Carcinoembryonic Antigen (CEA) | Semantic Scholar
Cancers | Free Full-Text | Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine
Preoperative CA 125 Levels: An Independent Prognostic Factor for Epithelial Ovarian Cancer | Semantic Scholar
